FDA Approves Onivyde Combination for Metastatic Pancreatic Cancer
THURSDAY, Feb. 15, 2024 (HealthDay News) -- The U.S. Food and Drug Administration has approved Onivyde (irinotecan liposome injection) plus oxaliplatin, fluorouracil, and leucovorin (NALIRI...